UK approves first weight loss pill as GLP-1 tablet gets green light from MHRA
The UK's MHRA has approved the first oral GLP-1 receptor agonist tablet, semaglutide, for weight management in adults with obesity or weight-related health conditions. This provides a daily alternative to the previously available weekly injections.
Why it matters
The availability of an oral weight-loss medication could significantly increase patient compliance and accessibility for obesity treatment.
UK approves first weight loss pill as GLP-1 tablet gets green light from MHRA - The Times of India
The article provides factual information regarding a medical regulatory approval without bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in